Press release from Business Wire India
Source: GlaxoSmithKline Pharmaceuticals Limited
Monday, July 26, 2010 12:58 PM IST (07:28 AM GMT)
Editors: General: Consumer interest, Economy; Business: Banking & financial services, Business services, Financial Analyst, Healthcare, biotechnology & pharmaceutical, Stock exchanges
GlaxoSmithKline Pharmaceuticals Net Sales up 9%, Operating Profit before Investment Income Grows by 14% in Second Quarter of FY 2010
Mumbai, Maharashtra, India, Monday, July 26, 2010 -- (Business Wire India) -- GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the second quarter ended 30th June 2010. Net Sales of the pharmaceuticals business grew by 12% during the quarter. Overall, Net Sales have grown by 9% during the quarter ended 30th June 2010 and by 14% during the half year ended 30th June 2010.
The ongoing pharmaceuticals business continued to build with improvement in margins. Operating Profit before investment income grew by 14% during the quarter ended 30th June 2010 and by 18% during the half year ended 30th June 2010.
Commenting on the performance during the quarter, Dr. Hasit B. Joshipura, Managing Director, said, "The growth momentum continued in the pharmaceutical business with competitive growth in the mass markets, mass specialities and specialities businesses. During the quarter, sales of vaccines were significantly impacted on account of constraints on supply. The availability of vaccines, however, has been improving towards the end of the quarter."
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk-india.com.
To view the Unaudited Financial Results, please click on the link given below:
Unaudited Financial Results
Sunder Rajan, General Manager, Corporate Communications, GlaxoSmithKline Pharmaceuticals Limited, +91 (22) 24959203, firstname.lastname@example.org
CONSUMER, ECONOMY, BANKING, BUSINESS SERVICES, Financial Analyst, HEALTHCARE, STOCK EXCHANGES, GLAXO.NS, GLAXOPHARMA.BO
If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.
Submit your press release at http://www.businesswireindia.com